UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000040975
Receipt No. R000046747
Scientific Title A prospective study to verify the effectiveness of postoperative nutrition therapy with amino acid preparation for patients after pancreatectomy
Date of disclosure of the study information 2020/09/01
Last modified on 2020/07/06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A prospective study to verify the effectiveness of postoperative nutrition therapy with amino acid preparation for patients after pancreatectomy
Acronym A prospective study to verify the effectiveness of postoperative nutrition therapy with amino acid preparation for patients after pancreatectomy
Scientific Title A prospective study to verify the effectiveness of postoperative nutrition therapy with amino acid preparation for patients after pancreatectomy
Scientific Title:Acronym A prospective study to verify the effectiveness of postoperative nutrition therapy with amino acid preparation for patients after pancreatectomy
Region
Japan

Condition
Condition after pancreaticoduodenectomy and total pancreatectomy
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is to verify whether postoperative nutrition therapy with amino acid preparation contributes to the improvement of nutritional status in patients after pancreatectomy.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Serum albumin level 30 days after surgery
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Administration of amino acid preparations for 7 days or more from the second day after surgery
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)Patients 20 years old or more
2)Patients who have undergone pancreaticoduodenectomy or total pancreatectomy
Key exclusion criteria 1)Contraindication to amino acid preparations
2)With active double cancer(Excluding early gastrointestinal cancer radically resected by endoscopic treatment)
3)Dialysis patient
4)Continuous systemic steroid therapy
5)Pregnant or possibility of pregnancy or breastfeeding
6)Patient registered to the other study whose endpoints are same to this study
7) Judged by the investigator to be inappropriate for this study
Target sample size 25

Research contact person
Name of lead principal investigator
1st name Hirochika
Middle name
Last name Toyama
Organization Kobe University Hospital
Division name Division of Hepato-Biliary-Pancreatic surgery
Zip code 650-0017
Address 7-5-2 Kusunoki-cho, Chuo-ku, Kobe-shi, Hyogo, Japan
TEL 078-382-6302
Email toyama@med.kobe-u.ac.jp

Public contact
Name of contact person
1st name Yuta
Middle name
Last name Ogura
Organization Kobe University Hospital
Division name Division of Hepato-Biliary-Pancreatic surgery
Zip code 650-0017
Address 7-5-2 Kusunoki-cho, Chuo-ku, Kobe-shi, Hyogo, Japan
TEL 078-382-6302
Homepage URL
Email yutakobe@hotmail.co.jp

Sponsor
Institute Division of Hepato-Biliary-Pancreatic surgery,Kobe University Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kobe University Hospital Clinical Translational Research Center
Address 7-5-2 Kusunoki-cho, Chuo-ku, Kobe-shi, Hyogo, Japan
Tel 078-382-6669
Email kainyu@med.kobe-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 09 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2020 Year 06 Month 29 Day
Date of IRB
Anticipated trial start date
2020 Year 09 Month 01 Day
Last follow-up date
2024 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 07 Month 02 Day
Last modified on
2020 Year 07 Month 06 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046747

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.